Spero Therapeutics Stock Story
SPRO Stock | USD 1.42 0.02 1.39% |
About 54% of Spero Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Spero Therapeutics suggests that many traders are impartial. Spero Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Spero Therapeutics. The current market sentiment, together with Spero Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Spero Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Spero Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Spero daily returns and investor perception about the current price of Spero Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Spero |
Requested story not found. it has been either deleted or moved. View all stories for Spero Therapeutics.
Spero Therapeutics Latest Timeline
Spero Therapeutics is listed for 1.42. The company reported the previous year's revenue of 96.73 M. Net Income was 22.81 M with loss before overhead, payroll, taxes, and interest of (42.11 M).Check out Spero Therapeutics Hype Analysis, Spero Therapeutics Correlation and Spero Therapeutics Performance. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Spero Stock analysis
When running Spero Therapeutics' price analysis, check to measure Spero Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spero Therapeutics is operating at the current time. Most of Spero Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spero Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spero Therapeutics' price. Additionally, you may evaluate how the addition of Spero Therapeutics to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Spero Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share 0.43 | Revenue Per Share 1.969 | Quarterly Revenue Growth 0.55 | Return On Assets 0.109 |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.